| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |